UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD)

Historical Holders from Q1 2014 to Q1 2025

Symbol
UTMD on Nasdaq
CUSIP
917488108
Type / Class
Equity / Common Stock
Shares outstanding
3.39M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
2.3M
Holdings value
$141M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
112
Number of buys
56
Number of sells
-52
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RENAISSANCE TECHNOLOGIES LLC 6.7% $13.4M 231K Renaissance Technologies LLC Sep 30, 2024
BlackRock, Inc. 4.97% $9.81M 169K BlackRock, Inc. Dec 31, 2024
FMR LLC 2.7% $5.37M 92.4K FMR LLC Dec 31, 2024

Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Stock (UTMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 40.1K $2.26M +$52.2K $56.04 10
2024 Q4 2.3M $141M -$8.02M $61.47 112
2024 Q3 2.41M $161M +$1.5M $66.91 109
2024 Q2 2.4M $161M -$6.99M $66.81 100
2024 Q1 2.49M $177M -$8.58M $71.11 99
2023 Q4 2.5M $211M -$5.58M $84.22 86
2023 Q3 2.57M $221M +$1.88M $86.00 90
2023 Q2 2.55M $237M +$487K $93.20 88
2023 Q1 2.54M $241M +$8.53M $94.77 85
2022 Q4 2.55M $256M +$1.19M $100.53 80
2022 Q3 2.54M $216M -$31.3M $85.31 74
2022 Q2 2.55M $219M -$1.11M $85.90 72
2022 Q1 2.57M $231M -$2.18M $89.86 81
2021 Q4 2.51M $251M -$298K $100.00 75
2021 Q3 2.6M $241M +$234K $92.83 71
2021 Q2 2.6M $221M -$2.72M $85.04 67
2021 Q1 2.63M $228M +$450K $86.60 77
2020 Q4 2.43M $205M -$3.58M $84.30 74
2020 Q3 2.48M $198M -$2.81M $79.87 80
2020 Q2 2.68M $238M +$3.96M $88.62 90
2020 Q1 2.63M $247M -$14.1M $94.05 87
2019 Q4 2.77M $299M -$7.83M $107.90 94
2019 Q3 2.85M $273M +$7.81M $95.84 92
2019 Q2 2.69M $258M +$3.43M $95.70 94
2019 Q1 2.67M $235M +$167K $88.25 87
2018 Q4 2.68M $223M -$3.35M $83.08 82
2018 Q3 2.79M $263M +$18.7M $94.20 88
2018 Q2 2.59M $285M +$1.05M $110.15 90
2018 Q1 2.59M $256M +$9.12M $98.85 77
2017 Q4 2.5M $203M +$2.19M $81.40 77
2017 Q3 2.46M $181M +$282K $73.55 72
2017 Q2 2.48M $179M +$4.87M $72.40 74
2017 Q1 2.42M $151M +$6.33M $62.30 75
2016 Q4 2.48M $180M -$463K $72.75 75
2016 Q3 2.5M $150M -$1.27M $59.80 78
2016 Q2 2.52M $159M -$2.05M $63.00 75
2016 Q1 2.56M $160M +$3.08M $62.54 68
2015 Q4 2.53M $148M +$2.33M $58.54 64
2015 Q3 2.47M $133M -$505K $53.87 58
2015 Q2 2.42M $144M +$3.68M $59.63 62
2015 Q1 2.41M $144M -$2.25M $59.86 58
2014 Q4 2.47M $148M -$16.2K $60.05 59
2014 Q3 2.21M $108M -$11.7M $48.76 60
2014 Q2 2.43M $125M +$1.47M $51.44 60
2014 Q1 2.4M $139M +$3.54M $57.83 58